Zobrazeno 1 - 10
of 291
pro vyhledávání: '"P. Nisipeanu"'
Publikováno v:
Theoretical and Applied Economics, Vol XXI, Iss 4, Pp 113-130 (2014)
Small and medium-sized enterprises represent an essential economic agent, on whose activity and performance depend large segments of the population and of the economy. To study the competitiveness of SMEs were pursued issues in these areas: managemen
Externí odkaz:
https://doaj.org/article/ef34c4cb24054c6e9fbcaeebc87cc1e2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Vision Research. 44:2793-2797
Retinal dopamine loss in Parkinson disease (PD) is reflected by visual neurophysiological dysfunction. We measured the thickness of the circumpapillary retinal nerve fiber layer (RNFL) in PD patients using optical coherence tomography. The thickness
Autor:
Evan Reid, P. Nisipeanu, Aziz Mazarib, David Withers, Sergiu C. Blumen, Saif Abu-Mouch, Michael Kahana, Rifka Inzelberg, Simon Bevan, R.L. Carasso, Ruth Navon, David Negus, Ahmad Mahamid, Hanoch Slor
Publikováno v:
Annals of Neurology. 54:796-803
We updated the clinical features of a consanguineous Arab Israeli family, in which four of seven children were affected by spastic paraplegia complicated by skin pigmentary abnormalities. A genomewide linkage screen performed for the family identifie
Autor:
P. Nisipeanu, Noa Berar-Yanay, Rivka Inzelberg, Avi Davidovich, Paltiel Weiner, R.L. Carasso, Rasmi Magadle
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 29:68-72
Background:Pulmonary and respiratory muscle function impairment are common in patients with Parkinson's disease (PD). However, dyspnea is not a frequent complaint among these patients, although it is well documented that the intensity of dyspnea is r
Autor:
H. Lavoie, Rivka Inzelberg, Bernard Brais, A. Asherov, P. Nisipeanu, R.L. Carasso, Guy A. Rouleau, Fernando M.S. Tomé, S. Medynski, Sergiu C. Blumen, Amos D. Korczyn, Joab Chapman, Jean-Pierre Bouchard
Publikováno v:
Neurology. 55:1267-1270
Objective: To determine whether all cases of oculopharyngeal muscular dystrophy (OPMD) among Bukhara Jews share the same founder mutation. Background: Autosomal dominant OPMD is caused by a (GCG) 8–13 repeat expansion in the polyadenylation binding
A Comparison of Dopamine Agonists and Catechol-O-Methyltransferase Inhibitors in Parkinson's Disease
Publikováno v:
Clinical Neuropharmacology. 23:262-266
To compare the efficacy and tolerability of three dopamine agonists--pergolide (PRG), pramipexole (PRX), and ropinirole (ROP)-and two catechol-O-methyltranferase (COMT) inhibitors-tolcapone (TOL) and entacapone (ENT)-as add-on therapies to levodopa (
Autor:
P. Nisipeanu, Bernard Brais, A. Asherov, François Codère, Joab Chapman, Michel Fardeau, Susan Medinsky, Jean-Pierre Bouchard, Sergiu C. Blumen, Amos D. Korczyn, Guy A. Rouleau, Fernando M.S. Tomé
Publikováno v:
Annals of Neurology. 46:115-118
Autosomal dominant oculopharyngeal muscular dystrophy (OPMD) usually begins with ptosis or dysphagia during the fifth or sixth decade of life. We studied 7 patients with OPMD symptoms starting before the age of 36 years. All were found to be homozygo
Autor:
Amos D. Korczyn, P. Nisipeanu
Publikováno v:
European Journal of Neurology. 3:417-423
The use of plasmapheresis in Guillain-Barre syndrome is reviewed. The clinical data, based on open-label studies, suggest that PP – if instituted early – prevents further deterioration and accelerates the recovery, e.g. the time until the patient
Autor:
S. Kippervasser, P. Nisipeanu, Rivka Inzelberg, Edna Schechtman, E. Orlov, J. M. Rabey, Amos D. Korczyn, T. Catz
Publikováno v:
Neurology. 47:785-788
In the present study we compared the efficacy and safety of the new dopamine agonist cabergoline (CBG) with bromocriptine (BCR) in Parkinson's disease (PD).CBG has a very long half-life and can be administered as a single daily dose. Forty-four PD pa